GGrantIndex
Sort

40,608 grants matching prostate cancer

Preventing invasive prostate cancer

$508,994
Raymond C Bergan · University Of Nebraska Medical Center · R01 · FY2024 · CA

A transdisciplinary approach for dissecting stem cell states in prostate cancer

$508,914
Raul Rabadan · Columbia University Health Sciences · U01 · FY2023 · CA

PROMISS - Prostate Modeling to Identify Surveillance Strategies

$508,879
Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA

Developing Selective EphA2 Inhibitors for the treatment of Cancer

$508,812
Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2014 · CA

Endothelin mechanisms in metastic prostate cancer pain

$508,805
Gary R Strichartz · Brigham And Women'S Hospital · R01 · FY2010 · CA

GENETICS OF PROSTATE CANCER SUSCEPTIBILITY

$508,761
Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA

"Molecular Signatures of Lethal and Indolent Prostate Cancer"

$508,718
Mark A. Rubin · Brigham And Women'S Hospital · R01 · FY2007 · CA

UCLA Clinical Scientist Training in Cancer Gene Medicine

$508,680
James S. Economou · University Of California Los Angeles · K12 · FY2006 · CA

UCLA Clinical Scientist Training in Cancer Gene Medicine

$508,680
University Of California Los Angeles · K12 · FY2004 · CA

UCLA Clinical Scientist Training in Cancer Gene Medicine

$508,680
University Of California Los Angeles · K12 · FY2005 · CA

UCLA Clinical Scientist Training in Cancer Gene Medicine

$508,680
James S. Economou · University Of California Los Angeles · K12 · FY2007 · CA

HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers

$508,654
Douglas F Nixon · George Washington University · R01 · FY2017 · CA

Shared Resources Core-1: Integrated Clinical, Tissue, and Biomarker Data Base Core (ICTBD Core)

$508,485
Jaydutt V Vadgama · Charles R. Drew University Of Med & Sci · U54 · FY2015 · CA

Quantitative histopathology for cancer prognosis using quantitative phase imaging on stained tissues

$508,306
Gabriel Popescu · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA

GENETIC EPIDEMIOLOGY OF PROSTATE CANCER AGGRESSIVENESS

$508,298
University Of California San Francisco · R01 · FY2003 · CA

Role and targeting of PRMT5 in prostate cancer

$508,108
Chang-Deng Hu · Purdue University · R01 · FY2020 · CA

Chemical markers of heterocyclic aromatic amines for human biomonitoring

$507,963
Robert J. Turesky · University Of Minnesota · R01 · FY2014 · CA

Targeting the cGAS/STING Pathway to Overcome Resistance to Immune Checkpoint Inhibitors in PTEN-deficient Prostate Cancer

$507,942
Akash Patnaik · University Of Chicago · R01 · FY2024 · CA

Targeting MED31-driven transcription recycling in lethal prostate cancer

$507,799
Qianben Wang · Duke University · R01 · FY2023 · CA

Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens

$507,690
Arthur Andrew Hurwitz · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK

$507,677
Philip Lazarus · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · DE

Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling

$507,671
Jacob Gardinier Scott · Cleveland Clinic Lerner Com-Cwru · U01 · FY2024 · CA

15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi

$507,599
Li Li · Case Western Reserve University · U01 · FY2017 · CA

Genetic Epidemiology of Prostate Cancer Aggressiveness

$507,563
John S Witte · University Of California, San Francisco · R01 · FY2007 · CA

A Prospective Study of Diet and Prostate Cancer

$507,538
Edward Giovannucci · Harvard School Of Public Health · P01 · FY2007 · CA